Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health aFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value ($M)
Annual figures from Elevance Health's filings and investor materials
Latest, FY2025
4,208
Period ended Dec 31, 2025
Change on a year earlier
-36.7%
6,649 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | AFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,208 | -36.7% | ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗ |
| FY2024 | Dec 31, 2024 | 6,649 | -55.2% | ELV 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗ |
| FY2023 | Dec 31, 2023 | 14,842 | +96.9% | ELV 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗ |
| FY2022 | Dec 31, 2022 | 7,537 | – | ELV 10-K (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗ |
Breakdown
What makes up afs securities in continuous unrealized loss position (≥ 12 months) — fair value
Cite this data
StockData. (2026). Elevance Health AFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value ($M), annual FY2022–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv_loss_pos_ge12m_fv
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.